Copyright
©The Author(s) 2018.
World J Clin Oncol. Dec 20, 2018; 9(8): 188-199
Published online Dec 20, 2018. doi: 10.5306/wjco.v9.i8.188
Published online Dec 20, 2018. doi: 10.5306/wjco.v9.i8.188
Figure 3 4T-1 Breast tumor volume in mice immunized with PBS buffer, 20 µg Survivin + Mycobacterium indicus pranii, 20 µg luteinizing hormone-releasing hormone + Mycobacterium indicus pranii and combination of 20 µg Survivin and 20 µg luteinizing hormone-releasing hormone along with Mycobacterium indicus pranii.
Tumor volume is measured at different time points from day 19th when tumor was palpable. LHRH: Luteinizing hormone-releasing hormone.
- Citation: Garg H, Hada RS, Gupta JC, Talwar GP, Dubey S. Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model. World J Clin Oncol 2018; 9(8): 188-199
- URL: https://www.wjgnet.com/2218-4333/full/v9/i8/188.htm
- DOI: https://dx.doi.org/10.5306/wjco.v9.i8.188